3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
6
Pancreatic Neoplasms
3
Pancreatic Cyst
2
Breast Neoplasms
2
Wilms Tumor
1
Uveal Melanoma
1
Thyroid Nodule
1
Thyroid Diseases
1
Prostatic Neoplasms
1
Peutz-Jeghers Syndrome
1
Pancreatitis, Chronic
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lung Neoplasms
1
Leukemia
1
Intestinal Neuroendocrine Tumor
1
Hyperthyroidism
1
Hip Fractures
1
Hematologic Neoplasms
1
Goiter
1
Glioma
1
Glioblastoma
1
Frailty
1
Fractures, Spontaneous
1
Interventions
pembrolizumab
16
Nivolumab
15
Ipilimumab
12
cemiplimab
10
aldesleukin
6
Interleukin-2
6
Cyclophosphamide
6
fludarabine
5
fludarabine phosphate
4
encorafenib
4
binimetinib
4
Blood Specimen Collection
4
avelumab
3
Sirolimus
3
trametinib
2
spartalizumab
2
lifileucel
2
dabrafenib
2
atezolizumab
2
Vemurafenib
2
Surgical Procedures, Operative
2
Specimen Handling
2
Radiotherapy
2
Prednisone
2
Niacinamide
2
Exercise
2
Everolimus
2
Dermoscopy
2
Biopsy
2
urelumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
Data Collection
×
1 year
×
Clear all
No trials found.